| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |